An improved method for the derivation of high quality iPSCs in the absence of c-Myc

Experimental Cell Research

Volumn 319, Issue 20, 2013, Pages 3190-3200

  Habib, Omer ^a,d   Habib, Gizem ^a,d   Choi, Hyun Woo ^b   Hong, Ki Sung ^c   Tae Do, Jeong ^b   Moon, Sung Hwan ^d   Chung, Hyung Min ^a,c,d  

^a CHA University   (South Korea)

^b Konkuk University   (South Korea)

^c CHA Stem Cell Institute   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

Author keywords

C Myc; Induced pluripotent stem cells; Reprogramming kinetics

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; DERIVATIZATION; EMBRYONIC STEM CELL; FIBROBLAST; GENE EXPRESSION; IN VITRO STUDY; MEDIATOR; MOUSE EMBRYONIC FIBROBLAST CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SERUM; SIGNAL TRANSDUCTION;

MUS;

EID: 84887135802     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.09.014     Document Type: Article

References (54)

1. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
2. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
3. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
4. Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes & Development 2010, 24:2239-2263.
5. Colman A., Dreesen O. Pluripotent stem cells and disease modeling. Cell Stem Cell 2009, 5:244-247.
6. Onder T.T., Daley G.Q. New lessons learned from disease modeling with induced pluripotent stem cells. Current Opinion in Genetics & Development 2012, 22:500-508.
7. Feng B., Ng J.H., Heng J.C., Ng H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009, 4:301-312.
8. Wernig M., Lengner C.J., Hanna J., Lodato M.A., Steine E., Foreman R., Staerk J., Markoulaki S., Jaenisch R. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nature Biotechnology 2008, 26:916-924.
9. Maherali N., Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 2008, 3:595-605.
10. Knoepfler P.S. Why myc? An unexpected ingredient in the stem cell cocktail. Cell Stem Cell 2008, 2:18-21.
11. Kim J., Woo A.J., Chu J., Snow J.W., Fujiwara Y., Kim C.G., Cantor A.B., Orkin S.H. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010, 143:313-324.
12. Zhang J., Nuebel E., Daley G.Q., Koehler C.M., Teitell M.A. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 2012, 11:589-595.
13. Sridharan R., Tchieu J., Mason M.J., Yachechko R., Kuoy E., Horvath S., Zhou Q., Plath K. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009, 136:364-377.
14. Soufi A., Donahue G., Zaret K.S. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 2012, 151:994-1004.
15. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
16. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology 2008, 26:101-106.
17. Wernig M., Meissner A., Cassady J.P., Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008, 2:10-12.
18. Araki R., Hoki Y., Uda M., Nakamura M., Jincho Y., Tamura C., Sunayama M., Ando S., Sugiura M., Yoshida M.A., Kasama Y., Abe M. Crucial role of c-Myc in the generation of induced pluripotent stem cells. Stem Cells 2011, 29:1362-1370.
19. Li W., Zhao X.Y., Wan H.F., Zhang Y., Liu L., Lv Z., Wang X.J., Wang L., Zhou Q. iPS cells generated without c-Myc have active Dlk1-Dio3 region and are capable of producing full-term mice through tetraploid complementation. Cell Research 2011, 21:550-553.
20. Jincho Y., Araki R., Hoki Y., Tamura C., Nakamura M., Ando S., Kasama Y., Abe M. Generation of genome integration-free induced pluripotent stem cells from fibroblasts of C57BL/6 mice without c-Myc transduction. Journal of Biological Chemistry 2010, 285:26384-26389.
21. Chen M., Zhang H., Wu J., Xu L., Xu D., Sun J., He Y., Zhou X., Wang Z., Wu L., Xu S., Wang J., Jiang S., Hoffman A.R., Hu X., Hu J., Li T. Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathway. Biomaterials 2012, 33:5514-5523.
22. Lohle M., Hermann A., Glass H., Kempe A., Schwarz S.C., Kim J.B., Poulet C., Ravens U., Schwarz J., Scholer H.R., Storch A. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells 2012, 30:570-579.
23. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008, 2:151-159.
24. Choi H.W., Kim J.S., Choi S., Jang H.J., Kim M.J., Choi Y., Scholer H.R., Chung H.M., Do J.T. Neural stem cells achieve and maintain pluripotency without feeder cells. PLoS One 2011, 6:e21367.
25. Ying Q.L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., Smith A. The ground state of embryonic stem cell self-renewal. Nature 2008, 453:519-523.
26. Morita S., Kojima T., Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Therapy 2000, 7:1063-1066.
27. Chen J., Liu J., Han Q., Qin D., Xu J., Chen Y., Yang J., Song H., Yang D., Peng M., He W., Li R., Wang H., Gan Y., Ding K., Zeng L., Lai L., Esteban M.A., Pei D. Towards an optimized culture medium for the generation of mouse induced pluripotent stem cells. Journal of Biological Chemistry 2010, 285:31066-31072.
28. Golipour A., David L., Liu Y., Jayakumaran G., Hirsch C.L., Trcka D., Wrana J.L. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network. Cell Stem Cell 2012, 11:769-782.
29. Stadtfeld M., Apostolou E., Akutsu H., Fukuda A., Follett P., Natesan S., Kono T., Shioda T., Hochedlinger K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010, 465:175-181.
30. Yao B., Li J., Huang H., Sun C., Wang Z., Fan Y., Chang Q., Li S., Xi J. Quantitative analysis of zeptomole microRNAs based on isothermal ramification amplification. RNA 2009, 15:1787-1794.
31. Han D.W., Do J.T., Gentile L., Stehling M., Lee H.T., Scholer H.R. Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle. Stem Cells 2008, 26:445-454.
32. Chen M., Huang J., Yang X., Liu B., Zhang W., Huang L., Deng F., Ma J., Bai Y., Lu R., Huang B., Gao Q., Zhuo Y., Ge J. Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One 2012, 7:e28203.
33. Stadtfeld M., Maherali N., Breault D.T., Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008, 2:230-240.
34. Silva J., Nichols J., Theunissen T.W., Guo G., van Oosten A.L., Barrandon O., Wray J., Yamanaka S., Chambers I., Smith A. Nanog is the gateway to the pluripotent ground state. Cell 2009, 138:722-737.
35. Liu L., Luo G.Z., Yang W., Zhao X., Zheng Q., Lv Z., Li W., Wu H.J., Wang L., Wang X.J., Zhou Q. Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. Journal of Biological Chemistry 2010, 285:19483-19490.
36. Stadtfeld M., Apostolou E., Ferrari F., Choi J., Walsh R.M., Chen T., Ooi S.S., Kim S.Y., Bestor T.H., Shioda T., Park P.J., Hochedlinger.K. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nature Genetics 2012, 44(398-405):S1-S2.
37. Marson A., Foreman R., Chevalier B., Bilodeau S., Kahn M., Young R.A., Jaenisch R. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008, 3:132-135.
38. Ichida J.K., Blanchard J., Lam K., Son E.Y., Chung J.E., Egli D., Loh K.M., Carter A.C., Di Giorgio F.P., Koszka K., Huangfu D., Akutsu H., Liu D.R., Rubin L.L., Eggan.K. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009, 5:491-503.
39. Feng B., Jiang J., Kraus P., Ng J.H., Heng J.C., Chan Y.S., Yaw L.P., Zhang W., Loh Y.H., Han J., Vega V.B., Cacheux-Rataboul V., Lim B., Lufkin T., Ng H.H. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nature Cell Biology 2009, 11:197-203.
40. Maekawa M., Yamaguchi K., Nakamura T., Shibukawa R., Kodanaka I., Ichisaka T., Kawamura Y., Mochizuki H., Goshima N., Yamanaka S. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 2011, 474:225-229.
41. Han J., Yuan P., Yang H., Zhang J., Soh B.S., Li P., Lim S.L., Cao S., Tay J., Orlov Y.L., Lufkin T., Ng H.H., Tam W.L., Lim B. Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 2010, 463:1096-1100.
42. Chen J., Liu J., Chen Y., Yang J., Liu H., Zhao X., Mo K., Song H., Guo L., Chu S., Wang D., Ding K., Pei D. Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics. Cell Research 2011, 21:884-894.
43. Lee J., Sayed N., Hunter A., Au K.F., Wong W.H., Mocarski E.S., Pera R.R., Yakubov E., Cooke J.P. Activation of innate immunity is required for efficient nuclear reprogramming. Cell 2012, 151:547-558.
44. Polo J.M., Anderssen E., Walsh R.M., Schwarz B.A., Nefzger C.M., Lim S.M., Borkent M., Apostolou E., Alaei S., Cloutier J., Bar-Nur O., Cheloufi S., Stadtfeld M., Figueroa M.E., Robinton D., Natesan S., Melnick A., Zhu J., Ramaswamy S., Hochedlinger K. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
45. Samavarchi-Tehrani P., Golipour A., David L., Sung H.K., Beyer T.A., Datti A., Woltjen K., Nagy A., Wrana J.L. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.
46. Buganim Y., Faddah D.A., Cheng A.W., Itskovich E., Markoulaki S., Ganz K., Klemm S.L., van Oudenaarden A., Jaenisch R. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 2012, 150:1209-1222.
47. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
48. Silva J., Barrandon O., Nichols J., Kawaguchi J., Theunissen T.W., Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biology 2008, 6:e253.
49. Chen J., Liu H., Liu J., Qi J., Wei B., Yang J., Liang H., Chen Y., Wu Y., Guo L., Zhu J., Zhao X., Peng T., Zhang Y., Chen S., Li X., Li D., Wang T., Pei D. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nature Genetics 2013, 45:34-42.
50. Mattout A., Biran A., Meshorer. Global epigenetic changes during somatic cell reprogramming to iPS cells. Journal of Molecular Cell Biology 2011, 3:341-350.
51. Gaspar-Maia A., Alajem A., Meshorer E., Ramalho-Santos M. Open chromatin in pluripotency and reprogramming. Nature Reviews Molecular Cell Biology 2011, 12:36-47.
52. Orkin S.H., Hochedlinger K. Chromatin connections to pluripotency and cellular reprogramming. Cell 2011, 145:835-850.
53. Hanna J.H., Saha K., Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010, 143:508-525.
54. Adachi K., Scholer H.R. Directing reprogramming to pluripotency by transcription factors. Current Opinion in Genetics & Development 2012, 22:416-422.